Atomi Financial Group Inc. Has $1.58 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Atomi Financial Group Inc. lowered its position in shares of Danaher Co. (NYSE:DHR) by 19.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,892 shares of the conglomerate’s stock after selling 1,633 shares during the quarter. Atomi Financial Group Inc.’s holdings in Danaher were worth $1,582,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Decker Retirement Planning Inc. acquired a new position in Danaher during the fourth quarter worth $31,000. Teachers Insurance & Annuity Association of America acquired a new position in shares of Danaher during the 3rd quarter worth about $39,000. MidAtlantic Capital Management Inc. acquired a new position in shares of Danaher during the 3rd quarter worth about $40,000. FSA Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter valued at about $50,000. Finally, Darwin Wealth Management LLC bought a new stake in Danaher during the third quarter worth about $55,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Robert W. Baird decreased their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Evercore ISI raised their target price on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. TD Cowen upped their price target on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Barclays decreased their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Finally, Citigroup dropped their target price on shares of Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $285.55.

Danaher Price Performance

Shares of Danaher stock opened at $244.18 on Wednesday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $176.36 billion, a price-to-earnings ratio of 46.60, a price-to-earnings-growth ratio of 4.30 and a beta of 0.83. Danaher Co. has a twelve month low of $225.42 and a twelve month high of $281.70. The company has a 50-day simple moving average of $234.75 and a two-hundred day simple moving average of $253.50.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same period in the previous year, the company posted $2.02 earnings per share. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. Analysts forecast that Danaher Co. will post 7.49 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.